Levofloxacina Aurovitas

Levofloxacin, the active ingredient in Levofloxacina Aurovitas, is a fluoroquinolone presented as an oral tablet for oral use. It treats a broad spectrum of bacterial infections in adult patients, including respiratory, urinary, and skin infections. GNH USA supplies Levofloxacina Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacina Aurovitas is a fluoroquinolone antibiotic used to treat bacterial infections in several organ systems. - Community‑acquired respiratory tract infection: eradicates susceptible pathogens and improves respiratory symptoms. - Urinary tract infection: clears causative bacteria and resolves urinary symptoms. - Skin and soft tissue infection: eliminates skin pathogens and promotes wound healing. - Intra‑abdominal infection: targets mixed aerobic and anaerobic organisms in the abdominal cavity. - Gonorrhea: provides effective antimicrobial activity against Neisseria gonorrhoeae.

Levofloxacina Aurovitas may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools that may be watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness or unsteadiness.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or loss of function, especially in the Achilles. - QT interval prolongation: potential cardiac arrhythmia risk. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention.

Before prescribing Levofloxacina Aurovitas, clinicians should consider several safety measures. - Assess renal function: adjust therapy in patients with impaired clearance. - Avoid use in patients with known hypersensitivity to fluoroquinolones. - Monitor for tendon pain or inflammation: discontinue if symptoms develop. - Use caution in patients with cardiac arrhythmias: QT prolongation may occur. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Levofloxacina Aurovitas can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids or supplements containing aluminum, magnesium, calcium, or iron: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Cyclosporine: elevated cyclosporine levels can lead to nephrotoxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of central nervous system stimulation. - Insulin: enhanced hypoglycaemic effect may require dose adjustment. - Oral hypoglycaemic agents: potential for increased blood‑sugar lowering; monitor glucose closely.